

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 5.69031333 |
| 2 | translational termination (GO:0006415) | 5.30752293 |
| 3 | ribosomal small subunit biogenesis (GO:0042274) | 5.16616602 |
| 4 | regulation of mononuclear cell migration (GO:0071675) | 4.46942103 |
| 5 | negative regulation of interleukin-12 production (GO:0032695) | 4.43937080 |
| 6 | protein targeting to ER (GO:0045047) | 4.29025545 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.20888658 |
| 8 | amino sugar catabolic process (GO:0046348) | 4.20356023 |
| 9 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.18529576 |
| 10 | cotranslational protein targeting to membrane (GO:0006613) | 4.12266556 |
| 11 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.10327389 |
| 12 | viral life cycle (GO:0019058) | 4.05084136 |
| 13 | translational elongation (GO:0006414) | 4.03371416 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 3.94880921 |
| 15 | respiratory electron transport chain (GO:0022904) | 3.94408325 |
| 16 | virion attachment to host cell (GO:0019062) | 3.93644774 |
| 17 | adhesion of symbiont to host cell (GO:0044650) | 3.93644774 |
| 18 | electron transport chain (GO:0022900) | 3.82632555 |
| 19 | cellular protein complex disassembly (GO:0043624) | 3.73712022 |
| 20 | ATP synthesis coupled proton transport (GO:0015986) | 3.73028030 |
| 21 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.73028030 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.71733137 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 3.63429797 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.61980812 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61980812 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.57367341 |
| 27 | oligosaccharide catabolic process (GO:0009313) | 3.54447331 |
| 28 | regulation of mast cell degranulation (GO:0043304) | 3.42887620 |
| 29 | adhesion of symbiont to host (GO:0044406) | 3.38290875 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.33578424 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33180535 |
| 32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33180535 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33180535 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 3.33180535 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33180535 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 3.33180535 |
| 37 | translational initiation (GO:0006413) | 3.26190732 |
| 38 | detection of other organism (GO:0098543) | 3.25922540 |
| 39 | glycolipid catabolic process (GO:0019377) | 3.24742836 |
| 40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.24445251 |
| 41 | positive regulation of lipid storage (GO:0010884) | 3.14047786 |
| 42 | phagosome maturation (GO:0090382) | 3.13298242 |
| 43 | positive regulation of mast cell activation (GO:0033005) | 3.10380176 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.09104734 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.07899857 |
| 46 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.07478315 |
| 47 | positive regulation of mast cell degranulation (GO:0043306) | 3.07478315 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.06029846 |
| 49 | detection of bacterium (GO:0016045) | 3.04718039 |
| 50 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.03398618 |
| 51 | cellular response to virus (GO:0098586) | 3.02104074 |
| 52 | protein complex disassembly (GO:0043241) | 3.01913660 |
| 53 | ribosomal large subunit biogenesis (GO:0042273) | 3.01495376 |
| 54 | cytidine metabolic process (GO:0046087) | 3.00891453 |
| 55 | cytidine catabolic process (GO:0006216) | 3.00891453 |
| 56 | cytidine deamination (GO:0009972) | 3.00891453 |
| 57 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00508357 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 2.96671523 |
| 59 | protein targeting to membrane (GO:0006612) | 2.96366004 |
| 60 | response to peptidoglycan (GO:0032494) | 2.94350723 |
| 61 | barbed-end actin filament capping (GO:0051016) | 2.94320323 |
| 62 | ceramide catabolic process (GO:0046514) | 2.93473131 |
| 63 | regulation of sequestering of triglyceride (GO:0010889) | 2.92114893 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89036536 |
| 65 | T-helper 1 type immune response (GO:0042088) | 2.85151658 |
| 66 | cellular extravasation (GO:0045123) | 2.84741457 |
| 67 | regulation of early endosome to late endosome transport (GO:2000641) | 2.84650530 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84132342 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.81496022 |
| 70 | regulation of mast cell activation (GO:0033003) | 2.81180436 |
| 71 | superoxide anion generation (GO:0042554) | 2.81006092 |
| 72 | negative regulation of interleukin-1 production (GO:0032692) | 2.80855275 |
| 73 | tooth mineralization (GO:0034505) | 2.80511052 |
| 74 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79202737 |
| 75 | macromolecular complex disassembly (GO:0032984) | 2.76720664 |
| 76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74866010 |
| 77 | macrophage activation (GO:0042116) | 2.73630738 |
| 78 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.73461327 |
| 79 | respiratory burst (GO:0045730) | 2.71534921 |
| 80 | detection of biotic stimulus (GO:0009595) | 2.69703535 |
| 81 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.69643341 |
| 82 | pattern specification involved in kidney development (GO:0061004) | 2.69343856 |
| 83 | immunoglobulin mediated immune response (GO:0016064) | 2.69076907 |
| 84 | sarcomere organization (GO:0045214) | 2.68547576 |
| 85 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.67648746 |
| 86 | response to host immune response (GO:0052572) | 2.67144246 |
| 87 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67144246 |
| 88 | response to increased oxygen levels (GO:0036296) | 2.65417290 |
| 89 | response to hyperoxia (GO:0055093) | 2.65417290 |
| 90 | negative regulation of interleukin-6 production (GO:0032715) | 2.65313191 |
| 91 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.65172323 |
| 92 | maternal placenta development (GO:0001893) | 2.63641586 |
| 93 | protein neddylation (GO:0045116) | 2.63615340 |
| 94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.63296514 |
| 95 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.63266888 |
| 96 | neutrophil activation (GO:0042119) | 2.62672757 |
| 97 | regulation of monocyte chemotaxis (GO:0090025) | 2.62063610 |
| 98 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.59909805 |
| 99 | regulation of antigen processing and presentation (GO:0002577) | 2.57904046 |
| 100 | cellular response to nicotine (GO:0071316) | 2.57305957 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56935162 |
| 102 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.56746266 |
| 103 | low-density lipoprotein particle clearance (GO:0034383) | 2.55656113 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53940322 |
| 105 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.53846661 |
| 106 | positive regulation of protein kinase C signaling (GO:0090037) | 2.53320984 |
| 107 | sphingolipid catabolic process (GO:0030149) | 2.51726160 |
| 108 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.50701385 |
| 109 | regulation of cholesterol storage (GO:0010885) | 2.50600108 |
| 110 | membrane lipid catabolic process (GO:0046466) | 2.50513921 |
| 111 | response to muramyl dipeptide (GO:0032495) | 2.49670383 |
| 112 | protein localization to endosome (GO:0036010) | 2.49396323 |
| 113 | myeloid cell activation involved in immune response (GO:0002275) | 2.49303817 |
| 114 | eosinophil chemotaxis (GO:0048245) | 2.48855215 |
| 115 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.48695528 |
| 116 | response to host (GO:0075136) | 2.48187322 |
| 117 | response to host defenses (GO:0052200) | 2.48187322 |
| 118 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.48187322 |
| 119 | regulation of superoxide anion generation (GO:0032928) | 2.47698344 |
| 120 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.47581790 |
| 121 | NIK/NF-kappaB signaling (GO:0038061) | 2.46514482 |
| 122 | sulfur amino acid catabolic process (GO:0000098) | 2.46440146 |
| 123 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.46261944 |
| 124 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46032430 |
| 125 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45784982 |
| 126 | mannose metabolic process (GO:0006013) | 2.45338496 |
| 127 | response to acidic pH (GO:0010447) | 2.45227263 |
| 128 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.45031725 |
| 129 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.44017286 |
| 130 | growth hormone receptor signaling pathway (GO:0060396) | 2.42660184 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.42188759 |
| 132 | regulation of regulated secretory pathway (GO:1903305) | 2.41139154 |
| 133 | negative regulation of innate immune response (GO:0045824) | 2.40506783 |
| 134 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.40249956 |
| 135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.40087151 |
| 136 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.39499719 |
| 137 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.38230963 |
| 138 | reactive oxygen species biosynthetic process (GO:1903409) | 2.38152188 |
| 139 | monocyte chemotaxis (GO:0002548) | 2.37907943 |
| 140 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.36564232 |
| 141 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.35574449 |
| 142 | macrophage activation involved in immune response (GO:0002281) | 2.34428053 |
| 143 | short-term memory (GO:0007614) | 2.34326998 |
| 144 | cardiac muscle cell development (GO:0055013) | 2.34039700 |
| 145 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.30638283 |
| 146 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.29697476 |
| 147 | positive regulation of interferon-alpha production (GO:0032727) | 2.29688555 |
| 148 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.27427553 |
| 149 | aldehyde catabolic process (GO:0046185) | 2.27367024 |
| 150 | segment specification (GO:0007379) | 2.26193882 |
| 151 | regulation of p38MAPK cascade (GO:1900744) | 2.26047358 |
| 152 | negative regulation of macroautophagy (GO:0016242) | 2.25361313 |
| 153 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.24845494 |
| 154 | granulocyte activation (GO:0036230) | 2.22003435 |
| 155 | regulation of macrophage chemotaxis (GO:0010758) | 2.21102047 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.19871919 |
| 157 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.19798221 |
| 158 | nitric oxide biosynthetic process (GO:0006809) | 2.18628883 |
| 159 | diol metabolic process (GO:0034311) | 2.18380384 |
| 160 | cardiac cell development (GO:0055006) | 2.17505305 |
| 161 | regulation of lipid storage (GO:0010883) | 2.17352421 |
| 162 | glyoxylate metabolic process (GO:0046487) | 2.16456010 |
| 163 | positive regulation of antigen processing and presentation (GO:0002579) | 2.14544443 |
| 164 | eosinophil migration (GO:0072677) | 2.13844995 |
| 165 | short-chain fatty acid metabolic process (GO:0046459) | 2.12659088 |
| 166 | L-phenylalanine metabolic process (GO:0006558) | 2.12379632 |
| 167 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.12379632 |
| 168 | plasma lipoprotein particle clearance (GO:0034381) | 2.11689762 |
| 169 | maturation of SSU-rRNA (GO:0030490) | 2.11007731 |
| 170 | response to thyroid hormone (GO:0097066) | 2.10907754 |
| 171 | cysteine metabolic process (GO:0006534) | 2.10907619 |
| 172 | regulation of integrin activation (GO:0033623) | 2.10135003 |
| 173 | cardiac myofibril assembly (GO:0055003) | 2.09861774 |
| 174 | myeloid cell homeostasis (GO:0002262) | 2.09002891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.69938546 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22067614 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.89747293 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.94553082 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.80277307 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.70301065 |
| 7 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.50299670 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42376646 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37090780 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.28373143 |
| 11 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.28273288 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.26647581 |
| 13 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26053295 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.24502214 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.19792282 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16013643 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12689495 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.99851638 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98593505 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97349432 |
| 21 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89292288 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89232564 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88213410 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85747963 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83194326 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81559944 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77007412 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.73915880 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73261518 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72535000 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71139504 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67969987 |
| 33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.65323837 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64905815 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63751696 |
| 36 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.61959659 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60724672 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60715916 |
| 39 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.59933755 |
| 40 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.59933755 |
| 41 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.59933755 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58304780 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56271994 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.51345814 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51008992 |
| 46 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50687702 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.47748348 |
| 48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.47386889 |
| 49 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.46348983 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45410885 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44694009 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44229157 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.43809232 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43569717 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43387835 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40858545 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40045987 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39150651 |
| 59 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.38847242 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37059311 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35587682 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34864543 |
| 63 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32051495 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31028763 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29980802 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28942578 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28433455 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28379919 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28331901 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27234878 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25947267 |
| 72 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.25305364 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.23578783 |
| 74 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22894465 |
| 75 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.22731878 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22619035 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21625923 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18951487 |
| 79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.18104072 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17644420 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17220741 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16343811 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16096555 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15925653 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15656529 |
| 86 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15410395 |
| 87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14766063 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14346878 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14026104 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13922949 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13488248 |
| 92 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12376743 |
| 93 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12078886 |
| 94 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.11699068 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11383805 |
| 96 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.09651105 |
| 97 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09588074 |
| 98 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09587677 |
| 99 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09460270 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09413108 |
| 101 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08947226 |
| 102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08213340 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07125920 |
| 104 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.07017310 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06870574 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06797997 |
| 107 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.05756290 |
| 108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04888861 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04712456 |
| 110 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04423291 |
| 111 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03299833 |
| 112 | MAF_26560356_Chip-Seq_TH1_Human | 1.02547594 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02023694 |
| 114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01885590 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01671393 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01621785 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01199534 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00661939 |
| 119 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00586197 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99977247 |
| 121 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99356187 |
| 122 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98903931 |
| 123 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98721242 |
| 124 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98372379 |
| 125 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97383004 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97377749 |
| 127 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96020711 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95574201 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95561661 |
| 130 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95175395 |
| 131 | MAF_26560356_Chip-Seq_TH2_Human | 0.93572355 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93135905 |
| 133 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93125095 |
| 134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92257072 |
| 135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91579624 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90884042 |
| 137 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90754996 |
| 138 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89063569 |
| 139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88866769 |
| 140 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88441616 |
| 141 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88392406 |
| 142 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88292640 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88222911 |
| 144 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86448766 |
| 145 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86130434 |
| 146 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85534031 |
| 147 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83542084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.77210472 |
| 2 | MP0003646_muscle_fatigue | 3.61659894 |
| 3 | MP0003172_abnormal_lysosome_physiology | 2.99178926 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 2.97848817 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 2.66406031 |
| 6 | MP0009379_abnormal_foot_pigmentation | 2.65196630 |
| 7 | MP0003828_pulmonary_edema | 2.62991468 |
| 8 | MP0004510_myositis | 2.51479014 |
| 9 | MP0009840_abnormal_foam_cell | 2.31921037 |
| 10 | MP0005451_abnormal_body_composition | 2.30700973 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.24785183 |
| 12 | MP0003436_decreased_susceptibility_to | 2.20213656 |
| 13 | MP0006082_CNS_inflammation | 2.20015783 |
| 14 | MP0003724_increased_susceptibility_to | 2.04304497 |
| 15 | MP0000604_amyloidosis | 2.03671051 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.02584866 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.00412244 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.99712752 |
| 19 | MP0005360_urolithiasis | 1.90149372 |
| 20 | MP0002277_abnormal_respiratory_mucosa | 1.89821185 |
| 21 | MP0004858_abnormal_nervous_system | 1.86810346 |
| 22 | MP0003136_yellow_coat_color | 1.83727398 |
| 23 | MP0002998_abnormal_bone_remodeling | 1.82437495 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.81734219 |
| 25 | MP0003011_delayed_dark_adaptation | 1.75690366 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.74969094 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.73808415 |
| 28 | MP0005083_abnormal_biliary_tract | 1.72435513 |
| 29 | MP0001542_abnormal_bone_strength | 1.65827568 |
| 30 | MP0000343_altered_response_to | 1.62776444 |
| 31 | MP0002723_abnormal_immune_serum | 1.61757302 |
| 32 | MP0003279_aneurysm | 1.60093774 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56393110 |
| 34 | MP0009785_altered_susceptibility_to | 1.49328638 |
| 35 | MP0009278_abnormal_bone_marrow | 1.48078261 |
| 36 | MP0005330_cardiomyopathy | 1.45060089 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.41559906 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.40546646 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.40327252 |
| 40 | MP0001819_abnormal_immune_cell | 1.40288343 |
| 41 | MP0001800_abnormal_humoral_immune | 1.39601893 |
| 42 | MP0005671_abnormal_response_to | 1.38742871 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.38648693 |
| 44 | MP0005025_abnormal_response_to | 1.35928992 |
| 45 | MP0004130_abnormal_muscle_cell | 1.33987607 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.33314557 |
| 47 | MP0003879_abnormal_hair_cell | 1.33147967 |
| 48 | MP0003186_abnormal_redox_activity | 1.32280086 |
| 49 | MP0003315_abnormal_perineum_morphology | 1.31483181 |
| 50 | MP0000685_abnormal_immune_system | 1.31416612 |
| 51 | MP0009053_abnormal_anal_canal | 1.30701783 |
| 52 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30404462 |
| 53 | MP0005165_increased_susceptibility_to | 1.28147621 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.26604333 |
| 55 | MP0001958_emphysema | 1.24442879 |
| 56 | MP0002419_abnormal_innate_immunity | 1.23984343 |
| 57 | MP0001790_abnormal_immune_system | 1.23463368 |
| 58 | MP0005387_immune_system_phenotype | 1.23463368 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.22337043 |
| 60 | MP0008260_abnormal_autophagy | 1.21851638 |
| 61 | MP0002249_abnormal_larynx_morphology | 1.20931454 |
| 62 | MP0004019_abnormal_vitamin_homeostasis | 1.19286658 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.17801520 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.17783442 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.17454278 |
| 66 | MP0001835_abnormal_antigen_presentation | 1.16785590 |
| 67 | MP0009764_decreased_sensitivity_to | 1.13913207 |
| 68 | MP0003329_amyloid_beta_deposits | 1.11998061 |
| 69 | MP0004947_skin_inflammation | 1.10147925 |
| 70 | MP0002972_abnormal_cardiac_muscle | 1.09890687 |
| 71 | MP0003448_altered_tumor_morphology | 1.09264595 |
| 72 | MP0003195_calcinosis | 1.08820382 |
| 73 | MP0004084_abnormal_cardiac_muscle | 1.06705311 |
| 74 | MP0002796_impaired_skin_barrier | 1.05577656 |
| 75 | MP0005332_abnormal_amino_acid | 1.05467055 |
| 76 | MP0003183_abnormal_peptide_metabolism | 1.05181508 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.05154150 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 1.04624004 |
| 79 | MP0005385_cardiovascular_system_phenoty | 1.04624004 |
| 80 | MP0009250_abnormal_appendicular_skeleto | 1.03621959 |
| 81 | MP0005310_abnormal_salivary_gland | 1.03293762 |
| 82 | MP0000751_myopathy | 1.02742904 |
| 83 | MP0008469_abnormal_protein_level | 1.02205576 |
| 84 | MP0005166_decreased_susceptibility_to | 1.00752988 |
| 85 | MP0002282_abnormal_trachea_morphology | 1.00606552 |
| 86 | MP0002971_abnormal_brown_adipose | 0.98826496 |
| 87 | MP0001853_heart_inflammation | 0.97567275 |
| 88 | MP0003690_abnormal_glial_cell | 0.95117258 |
| 89 | MP0003137_abnormal_impulse_conducting | 0.95048247 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.94602174 |
| 91 | MP0009643_abnormal_urine_homeostasis | 0.94470093 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.93433626 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.93429222 |
| 94 | MP0004087_abnormal_muscle_fiber | 0.93211042 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.92591348 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.92551064 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.92551064 |
| 98 | MP0005023_abnormal_wound_healing | 0.92057062 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.91984935 |
| 100 | MP0000858_altered_metastatic_potential | 0.90697497 |
| 101 | MP0000049_abnormal_middle_ear | 0.89995330 |
| 102 | MP0008004_abnormal_stomach_pH | 0.89053018 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.88979865 |
| 104 | MP0004883_abnormal_blood_vessel | 0.88481618 |
| 105 | MP0010630_abnormal_cardiac_muscle | 0.88334820 |
| 106 | MP0002452_abnormal_antigen_presenting | 0.88151695 |
| 107 | MP0001663_abnormal_digestive_system | 0.87136401 |
| 108 | MP0002102_abnormal_ear_morphology | 0.86754735 |
| 109 | MP0002405_respiratory_system_inflammati | 0.86201226 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.85811006 |
| 111 | MP0004381_abnormal_hair_follicle | 0.85159578 |
| 112 | MP0003795_abnormal_bone_structure | 0.84922085 |
| 113 | MP0004484_altered_response_of | 0.84369748 |
| 114 | MP0000749_muscle_degeneration | 0.82983599 |
| 115 | MP0003075_altered_response_to | 0.82384531 |
| 116 | MP0005164_abnormal_response_to | 0.81544462 |
| 117 | MP0002132_abnormal_respiratory_system | 0.81300413 |
| 118 | MP0000490_abnormal_crypts_of | 0.81280408 |
| 119 | MP0000716_abnormal_immune_system | 0.81069603 |
| 120 | MP0008775_abnormal_heart_ventricle | 0.80174953 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.80168645 |
| 122 | MP0002653_abnormal_ependyma_morphology | 0.79543186 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.79222250 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.78724301 |
| 125 | MP0005365_abnormal_bile_salt | 0.78649091 |
| 126 | MP0003705_abnormal_hypodermis_morpholog | 0.77330590 |
| 127 | MP0006054_spinal_hemorrhage | 0.75644762 |
| 128 | MP0002106_abnormal_muscle_physiology | 0.75606607 |
| 129 | MP0005197_abnormal_uvea_morphology | 0.75500999 |
| 130 | MP0000613_abnormal_salivary_gland | 0.74852313 |
| 131 | MP0005390_skeleton_phenotype | 0.74797214 |
| 132 | MP0002254_reproductive_system_inflammat | 0.74107998 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.73839553 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.73772436 |
| 135 | MP0000249_abnormal_blood_vessel | 0.73354469 |
| 136 | MP0002933_joint_inflammation | 0.72447444 |
| 137 | MP0010155_abnormal_intestine_physiology | 0.71835361 |
| 138 | MP0000920_abnormal_myelination | 0.67020719 |
| 139 | MP0000371_diluted_coat_color | 0.66432610 |
| 140 | MP0003091_abnormal_cell_migration | 0.65862764 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.65774815 |
| 142 | MP0000681_abnormal_thyroid_gland | 0.62800020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.23162728 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.23162728 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.23162728 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.98039507 |
| 5 | Concave nail (HP:0001598) | 4.49544577 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.29781391 |
| 7 | Sudden death (HP:0001699) | 3.81008623 |
| 8 | Loss of speech (HP:0002371) | 3.80292688 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.74475590 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.74475590 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.74475590 |
| 12 | Abnormal hemoglobin (HP:0011902) | 3.67848313 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.40926903 |
| 14 | Ventricular tachycardia (HP:0004756) | 3.38892587 |
| 15 | Axonal loss (HP:0003447) | 3.38750617 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.34736850 |
| 17 | Myositis (HP:0100614) | 3.33160832 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.30994849 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.16946767 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.16848943 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.14162246 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.11577841 |
| 23 | Disinhibition (HP:0000734) | 3.10150701 |
| 24 | Acute encephalopathy (HP:0006846) | 3.08062678 |
| 25 | Vertebral compression fractures (HP:0002953) | 3.05782975 |
| 26 | Increased muscle lipid content (HP:0009058) | 3.03347378 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.02907340 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.01834527 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 2.96172391 |
| 30 | Multiple enchondromatosis (HP:0005701) | 2.95334663 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.94494561 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.92055499 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.88635431 |
| 34 | Purpura (HP:0000979) | 2.87372101 |
| 35 | Mitochondrial inheritance (HP:0001427) | 2.86259012 |
| 36 | Glomerulonephritis (HP:0000099) | 2.85822427 |
| 37 | Exertional dyspnea (HP:0002875) | 2.83487403 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 2.81820985 |
| 39 | Mutism (HP:0002300) | 2.80009686 |
| 40 | Nuclear cataract (HP:0100018) | 2.79846424 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.78220775 |
| 42 | Neurofibrillary tangles (HP:0002185) | 2.73851801 |
| 43 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.73686895 |
| 44 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.73686895 |
| 45 | Reticulocytopenia (HP:0001896) | 2.69737326 |
| 46 | Asymmetric septal hypertrophy (HP:0001670) | 2.69707724 |
| 47 | Prolonged neonatal jaundice (HP:0006579) | 2.62438958 |
| 48 | Abnormal cartilage morphology (HP:0002763) | 2.60135676 |
| 49 | Hepatic necrosis (HP:0002605) | 2.58683625 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.55364522 |
| 51 | Optic neuritis (HP:0100653) | 2.55364522 |
| 52 | Myocardial infarction (HP:0001658) | 2.55101430 |
| 53 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.54390910 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.53769507 |
| 55 | Progressive neurologic deterioration (HP:0002344) | 2.53411943 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52261501 |
| 57 | Hepatocellular necrosis (HP:0001404) | 2.50849070 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.49266013 |
| 59 | Cerebral edema (HP:0002181) | 2.46855395 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.45209817 |
| 61 | Progressive macrocephaly (HP:0004481) | 2.44425056 |
| 62 | Xanthomatosis (HP:0000991) | 2.41422191 |
| 63 | Respiratory failure (HP:0002878) | 2.40738993 |
| 64 | Nausea (HP:0002018) | 2.40604504 |
| 65 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.39592771 |
| 66 | Polycythemia (HP:0001901) | 2.39361837 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.38860077 |
| 68 | Macrocytic anemia (HP:0001972) | 2.35817142 |
| 69 | Petechiae (HP:0000967) | 2.34354404 |
| 70 | Pallor (HP:0000980) | 2.33513265 |
| 71 | Lipoatrophy (HP:0100578) | 2.30638231 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.30465814 |
| 73 | Abnormality of the nasal mucosa (HP:0000433) | 2.30437940 |
| 74 | Abnormality of the Achilles tendon (HP:0005109) | 2.28522952 |
| 75 | Esophageal neoplasm (HP:0100751) | 2.27222700 |
| 76 | Neoplasm of head and neck (HP:0012288) | 2.27222700 |
| 77 | Testicular atrophy (HP:0000029) | 2.27170864 |
| 78 | Achilles tendon contracture (HP:0001771) | 2.26911909 |
| 79 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.26690842 |
| 80 | Stomatitis (HP:0010280) | 2.25194977 |
| 81 | Malnutrition (HP:0004395) | 2.25001875 |
| 82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.22920980 |
| 83 | Joint stiffness (HP:0001387) | 2.21330641 |
| 84 | Pathologic fracture (HP:0002756) | 2.16749379 |
| 85 | Increased CSF lactate (HP:0002490) | 2.14579143 |
| 86 | Hematochezia (HP:0002573) | 2.13888190 |
| 87 | Upper motor neuron abnormality (HP:0002127) | 2.13720305 |
| 88 | Abnormal urine phosphate concentration (HP:0012599) | 2.12535893 |
| 89 | Fragile nails (HP:0001808) | 2.10669325 |
| 90 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.09870189 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.09781519 |
| 92 | Progressive muscle weakness (HP:0003323) | 2.09405882 |
| 93 | Hyperglycinuria (HP:0003108) | 2.08995577 |
| 94 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.08816380 |
| 95 | Urticaria (HP:0001025) | 2.08333516 |
| 96 | Abnormality of complement system (HP:0005339) | 2.07816330 |
| 97 | Protrusio acetabuli (HP:0003179) | 2.07608173 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05536610 |
| 99 | Obstructive lung disease (HP:0006536) | 2.05536610 |
| 100 | Diminished motivation (HP:0000745) | 2.05111143 |
| 101 | Orchitis (HP:0100796) | 2.04530989 |
| 102 | Nephritis (HP:0000123) | 2.04376170 |
| 103 | Amyloidosis (HP:0011034) | 2.04177363 |
| 104 | Cervical subluxation (HP:0003308) | 2.03971183 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.03568850 |
| 106 | Increased serum ferritin (HP:0003281) | 2.01817125 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.00662952 |
| 108 | Syncope (HP:0001279) | 2.00499559 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00205195 |
| 110 | Dicarboxylic aciduria (HP:0003215) | 2.00205195 |
| 111 | Ovoid vertebral bodies (HP:0003300) | 1.99205550 |
| 112 | Calf muscle hypertrophy (HP:0008981) | 1.98496198 |
| 113 | Hyperglycinemia (HP:0002154) | 1.96699973 |
| 114 | Muscle fiber splitting (HP:0003555) | 1.93751243 |
| 115 | Glycosuria (HP:0003076) | 1.93143234 |
| 116 | Abnormality of urine glucose concentration (HP:0011016) | 1.93143234 |
| 117 | Peritonitis (HP:0002586) | 1.93115430 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 1.92768562 |
| 119 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.92432897 |
| 120 | Cardiomegaly (HP:0001640) | 1.91039562 |
| 121 | Hemoptysis (HP:0002105) | 1.89592296 |
| 122 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.89033719 |
| 123 | Lethargy (HP:0001254) | 1.88969126 |
| 124 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88861361 |
| 125 | Recurrent skin infections (HP:0001581) | 1.88612432 |
| 126 | Cupped ribs (HP:0000887) | 1.88248350 |
| 127 | Complement deficiency (HP:0004431) | 1.86401294 |
| 128 | Ridged nail (HP:0001807) | 1.86266095 |
| 129 | Metaphyseal irregularity (HP:0003025) | 1.86217163 |
| 130 | Woolly hair (HP:0002224) | 1.85832302 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.85705246 |
| 132 | Hyperlipoproteinemia (HP:0010980) | 1.85363229 |
| 133 | Apathy (HP:0000741) | 1.84324168 |
| 134 | Retinal atrophy (HP:0001105) | 1.83939624 |
| 135 | Neuronal loss in central nervous system (HP:0002529) | 1.83436167 |
| 136 | Supranuclear gaze palsy (HP:0000605) | 1.83246169 |
| 137 | Autoimmune thrombocytopenia (HP:0001973) | 1.83195892 |
| 138 | Acne (HP:0001061) | 1.83180752 |
| 139 | Subaortic stenosis (HP:0001682) | 1.82588820 |
| 140 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82588820 |
| 141 | Dementia (HP:0000726) | 1.81902313 |
| 142 | Multiple lipomas (HP:0001012) | 1.80166859 |
| 143 | Bone pain (HP:0002653) | 1.80123633 |
| 144 | Abnormal number of erythroid precursors (HP:0012131) | 1.79771133 |
| 145 | Mucopolysacchariduria (HP:0008155) | 1.79685925 |
| 146 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79685925 |
| 147 | Gingivitis (HP:0000230) | 1.79427544 |
| 148 | Recurrent fungal infections (HP:0002841) | 1.79405514 |
| 149 | Thin bony cortex (HP:0002753) | 1.75563758 |
| 150 | Gout (HP:0001997) | 1.74907816 |
| 151 | Exercise intolerance (HP:0003546) | 1.74801626 |
| 152 | Thoracic kyphosis (HP:0002942) | 1.73987078 |
| 153 | Pustule (HP:0200039) | 1.73764085 |
| 154 | Abnormality of glycine metabolism (HP:0010895) | 1.73228264 |
| 155 | Hypophosphatemia (HP:0002148) | 1.71577380 |
| 156 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71441339 |
| 157 | Episodic fever (HP:0001954) | 1.70681790 |
| 158 | J-shaped sella turcica (HP:0002680) | 1.70647733 |
| 159 | Vasculitis (HP:0002633) | 1.70209432 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69928836 |
| 161 | Premature loss of primary teeth (HP:0006323) | 1.69190442 |
| 162 | Emphysema (HP:0002097) | 1.65996923 |
| 163 | Bone cyst (HP:0012062) | 1.64661304 |
| 164 | Premature rupture of membranes (HP:0001788) | 1.64425562 |
| 165 | Hypertensive crisis (HP:0100735) | 1.61409697 |
| 166 | Restrictive lung disease (HP:0002091) | 1.60542497 |
| 167 | Genu recurvatum (HP:0002816) | 1.59186459 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 4.96480477 |
| 2 | TAOK3 | 4.02679641 |
| 3 | NME2 | 3.76647902 |
| 4 | EPHB2 | 3.14686257 |
| 5 | BLK | 2.63156667 |
| 6 | MAP2K3 | 2.48042047 |
| 7 | ABL2 | 2.39046412 |
| 8 | TRIB3 | 2.34037162 |
| 9 | TBK1 | 2.21152240 |
| 10 | ERN1 | 2.19812092 |
| 11 | RIPK4 | 2.18939394 |
| 12 | LATS2 | 1.99147931 |
| 13 | PIM2 | 1.95233853 |
| 14 | MST1R | 1.81853763 |
| 15 | DMPK | 1.72145701 |
| 16 | MAP3K11 | 1.70647427 |
| 17 | DAPK3 | 1.69116579 |
| 18 | SIK1 | 1.66075012 |
| 19 | TAOK2 | 1.62415009 |
| 20 | MAP4K1 | 1.61880593 |
| 21 | IRAK3 | 1.58408235 |
| 22 | MAP3K13 | 1.52970396 |
| 23 | MAP2K2 | 1.51326014 |
| 24 | ILK | 1.50623046 |
| 25 | CDC42BPA | 1.38107394 |
| 26 | KSR2 | 1.37884909 |
| 27 | MOS | 1.35443763 |
| 28 | PRPF4B | 1.34021280 |
| 29 | DYRK2 | 1.30486151 |
| 30 | BCKDK | 1.25743129 |
| 31 | LIMK1 | 1.22387664 |
| 32 | PBK | 1.19381884 |
| 33 | MARK2 | 1.18754690 |
| 34 | DYRK3 | 1.15929454 |
| 35 | TESK1 | 1.15794921 |
| 36 | IKBKB | 1.14354599 |
| 37 | PKN2 | 1.09325279 |
| 38 | TTN | 1.07070259 |
| 39 | MYLK | 1.06941783 |
| 40 | TNK2 | 1.05563057 |
| 41 | TYK2 | 1.05122627 |
| 42 | TGFBR2 | 1.05083804 |
| 43 | FGR | 1.04462893 |
| 44 | CSK | 1.04116686 |
| 45 | ADRBK2 | 1.03309639 |
| 46 | NME1 | 1.03148648 |
| 47 | PTK6 | 1.02658687 |
| 48 | ARAF | 1.01626219 |
| 49 | MAP3K6 | 1.00357732 |
| 50 | PDPK1 | 1.00235913 |
| 51 | NEK9 | 0.99737786 |
| 52 | MATK | 0.98535142 |
| 53 | STK38L | 0.96356121 |
| 54 | RPS6KA2 | 0.95362462 |
| 55 | LATS1 | 0.94253961 |
| 56 | IRAK4 | 0.93648573 |
| 57 | BRAF | 0.90137024 |
| 58 | PHKG1 | 0.90001987 |
| 59 | PHKG2 | 0.90001987 |
| 60 | MAP3K1 | 0.89445377 |
| 61 | IKBKE | 0.88990858 |
| 62 | STK16 | 0.87806529 |
| 63 | MAP3K14 | 0.87579643 |
| 64 | IRAK1 | 0.86951052 |
| 65 | NLK | 0.86461611 |
| 66 | CAMK1D | 0.85544968 |
| 67 | TESK2 | 0.84842481 |
| 68 | BMX | 0.83291202 |
| 69 | DYRK1B | 0.83129651 |
| 70 | JAK3 | 0.82721511 |
| 71 | RPS6KC1 | 0.82526125 |
| 72 | RPS6KL1 | 0.82526125 |
| 73 | MARK3 | 0.82469942 |
| 74 | PRKD2 | 0.81668207 |
| 75 | LRRK2 | 0.80974436 |
| 76 | MAP3K10 | 0.80931544 |
| 77 | GRK7 | 0.80550561 |
| 78 | MST4 | 0.79534998 |
| 79 | RPS6KA6 | 0.78813211 |
| 80 | EPHB1 | 0.77870953 |
| 81 | WNK4 | 0.77813527 |
| 82 | MUSK | 0.77536520 |
| 83 | CAMKK2 | 0.77469150 |
| 84 | IRAK2 | 0.76460676 |
| 85 | KIT | 0.73102313 |
| 86 | PRKD1 | 0.71671711 |
| 87 | MAP2K6 | 0.70356493 |
| 88 | SIK2 | 0.69500681 |
| 89 | PRKG2 | 0.68705444 |
| 90 | ACVR1B | 0.67126505 |
| 91 | SIK3 | 0.67065465 |
| 92 | CDK9 | 0.66668372 |
| 93 | HCK | 0.66083626 |
| 94 | PRKAA2 | 0.65718156 |
| 95 | ABL1 | 0.64283851 |
| 96 | LYN | 0.64280724 |
| 97 | TAOK1 | 0.62943818 |
| 98 | GRK6 | 0.61050662 |
| 99 | BTK | 0.60501493 |
| 100 | PTK2B | 0.59962122 |
| 101 | RPS6KA4 | 0.59210406 |
| 102 | CSF1R | 0.58806599 |
| 103 | MAPK12 | 0.57260303 |
| 104 | MAP3K5 | 0.57082024 |
| 105 | ZAP70 | 0.56848503 |
| 106 | PAK1 | 0.56328673 |
| 107 | PDK1 | 0.56328435 |
| 108 | LMTK2 | 0.56218628 |
| 109 | CDK8 | 0.55725649 |
| 110 | SYK | 0.55491095 |
| 111 | MAPK15 | 0.54650650 |
| 112 | PAK4 | 0.53880685 |
| 113 | STK24 | 0.53692470 |
| 114 | ADRBK1 | 0.53528197 |
| 115 | MAP2K4 | 0.53170989 |
| 116 | GSK3A | 0.53170293 |
| 117 | ICK | 0.52925711 |
| 118 | PRKD3 | 0.52117882 |
| 119 | CAMK2D | 0.52091220 |
| 120 | CHUK | 0.52061385 |
| 121 | STK3 | 0.48859765 |
| 122 | PKN1 | 0.48680049 |
| 123 | JAK2 | 0.47865321 |
| 124 | MAPK7 | 0.45065097 |
| 125 | PTK2 | 0.45012102 |
| 126 | DAPK2 | 0.44660896 |
| 127 | LCK | 0.43956424 |
| 128 | TXK | 0.43831501 |
| 129 | ERBB4 | 0.40826600 |
| 130 | DDR2 | 0.40588071 |
| 131 | RIPK1 | 0.40309992 |
| 132 | PAK2 | 0.40218218 |
| 133 | MAPK4 | 0.40150657 |
| 134 | TIE1 | 0.39647137 |
| 135 | STK39 | 0.39579911 |
| 136 | HIPK2 | 0.39557825 |
| 137 | PRKCD | 0.39496989 |
| 138 | MAP3K3 | 0.39453226 |
| 139 | PIK3CA | 0.38942555 |
| 140 | MAPK11 | 0.38310885 |
| 141 | CDK19 | 0.37234872 |
| 142 | STK38 | 0.36823374 |
| 143 | FES | 0.36203125 |
| 144 | PAK6 | 0.34318967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.12486334 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.96536235 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 3.64002047 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.20013592 |
| 5 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.99751067 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.49009751 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.30363007 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28975118 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.16915401 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.13750806 |
| 11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.02322911 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.99105646 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.79228177 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70960317 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.68907650 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47494455 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43091302 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41030936 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40873007 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40308562 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.40237936 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.37046027 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35676195 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.34821996 |
| 25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31921943 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.26400429 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26006185 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21996146 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21751449 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19080283 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.17664364 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16846680 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16752377 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15998377 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13895014 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13382971 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.11077221 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.11038171 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10965283 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.08239337 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07789883 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07224977 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07039424 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05621138 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04181658 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03953442 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03483750 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02259960 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01831924 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.00064938 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99608447 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98896941 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.96654930 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95204183 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.94883206 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94199848 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92226636 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88226582 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87372433 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.85922654 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84230657 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84069431 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83647302 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83031261 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.82028665 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81510451 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80625812 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77890536 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77306884 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76938568 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74663846 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.71928304 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71762984 |
| 74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69732870 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68874847 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.68705106 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68434811 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67829581 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67122393 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65987371 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65739787 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65538202 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63530988 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62825220 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.62254279 |
| 86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61160689 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60606952 |
| 88 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59881049 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59263712 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58953336 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58681786 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57843977 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56871000 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56046578 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55189910 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54264463 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53258353 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52544453 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51933546 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.51242702 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50637124 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.50549256 |
| 103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50158079 |
| 104 | Allograft rejection_Homo sapiens_hsa05330 | 0.49206374 |
| 105 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48678046 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.48666518 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47344414 |
| 108 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47177898 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.46188434 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.45375930 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43049532 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42879615 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.42700766 |
| 114 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41824687 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.41768169 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.41230356 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40856381 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40787050 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40689263 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40378593 |
| 121 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39996672 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39729728 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36321433 |
| 124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36094298 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35968328 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.35804522 |
| 127 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34334109 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33858789 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.33845820 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33027192 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.30138389 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29945131 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29586305 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29490355 |
| 135 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28222321 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.27874971 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24891005 |
| 138 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24775693 |
| 139 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.24587336 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.23988476 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22407171 |

